"Medical Oncology" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subspecialty of internal medicine concerned with the study of neoplasms.
| Descriptor ID |
D008495
|
| MeSH Number(s) |
H02.403.429.515
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Medical Oncology".
Below are MeSH descriptors whose meaning is more specific than "Medical Oncology".
This graph shows the total number of publications written about "Medical Oncology" by people in this website by year, and whether "Medical Oncology" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1995 | 0 | 1 | 1 |
| 1997 | 2 | 2 | 4 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 3 | 1 | 4 |
| 2004 | 4 | 1 | 5 |
| 2005 | 1 | 1 | 2 |
| 2006 | 7 | 1 | 8 |
| 2007 | 8 | 3 | 11 |
| 2008 | 6 | 6 | 12 |
| 2009 | 2 | 9 | 11 |
| 2010 | 6 | 1 | 7 |
| 2011 | 5 | 4 | 9 |
| 2012 | 3 | 4 | 7 |
| 2013 | 7 | 6 | 13 |
| 2014 | 16 | 6 | 22 |
| 2015 | 9 | 2 | 11 |
| 2016 | 13 | 6 | 19 |
| 2017 | 11 | 4 | 15 |
| 2018 | 7 | 5 | 12 |
| 2019 | 19 | 2 | 21 |
| 2020 | 12 | 9 | 21 |
| 2021 | 13 | 15 | 28 |
| 2022 | 5 | 8 | 13 |
To return to the timeline,
click here.
Below are the most recent publications written about "Medical Oncology" by people in Profiles.
-
Onconephrology 2022: An Update. Kidney360. 2023 02 01; 4(2):258-271.
-
Serving on the FDA oncologic drugs advisory committee. Clin Adv Hematol Oncol. 2022 11; 20(11):649-651.
-
Precision oncology provides opportunities for targeting KRAS-inhibitor resistance. Trends Cancer. 2023 Jan; 9(1):42-54.
-
Advances in Multimodality Imaging in?Cardio-Oncology: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 10 18; 80(16):1560-1578.
-
Practice Considerations for Participation in the Enhancing Oncology Model. JCO Oncol Pract. 2022 11; 18(11):737-741.
-
Surgical considerations and outcomes of minimally invasive approaches for gastric cancer resection. Cancer. 2022 11 15; 128(22):3910-3918.
-
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022. Ann Oncol. 2023 01; 34(1):48-60.
-
An Expanded Role for IRBs in the Oversight of Research Biopsies. Ethics Hum Res. 2022 Sep; 44(5):32-41.
-
Oncology Drug Prescribing: The Influences of Greed and Fear. JCO Oncol Pract. 2022 09; 18(9):e1384-e1387.
-
Modern developments in germline pharmacogenomics for oncology prescribing. CA Cancer J Clin. 2022 07; 72(4):315-332.